NCMS member Dr. Hemant Solomon with WakeMed Heart & Vascular – Cardiology recently performed Wake County’s first procedure to implant Abbott’s AVEIR™ DR, the world’s first dual chamber leadless pacemaker system.
Approved by the FDA in June 2023, Abbott’s AVEIR DR is roughly one-tenth the size of a traditional pacemaker and provides a new minimally invasive option for patients who require pacing in two chambers of the heart. Primarily used for people with slow or irregular heart rhythms, the Abbott AVEIR DR uses innovative technology to wirelessly communicate and make sure the heart stays on beat.
Unlike traditional pacemakers, leadless devices are implanted directly into the heart through a minimally invasive procedure and eliminate the need for cardiac leads. This reduces exposure to potential lead and pocket-related complications and offers a less restrictive and shorter recovery period for patients.
Congratulations to Dr. Solomon and the WakeMed Cary Hospital Heart & Vascular Labs team!
For more information about WakeMed Heart & Vascular services, visit www.wakemed.org/hearts. [source]